Posaconazol Devatis 40mg/ml, Suspension zum Einnehmen
7680675940011
CH-67594
suspension
Associated product:
POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml
1 / 3
google
Article details
- Package size
- 105
- Selling units
- 105
- Measure
- ml
- Galenic form
- suspension
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1750.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
0.045 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
14.35 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 574.50
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2021
Authorization holder
Devatis AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 67594
- Drug name
- Posaconazol Devatis, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- J02AC04
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 06/08/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.06.0.
- Domain
- Human medicine
Package details
- Description (FR)
- POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml
- Description (DE)
- POSACONAZOL Devatis Susp 40 mg/ml z Einnehm 105 ml
- Market launch
- 06/08/2020
- Narcotic (BTM)
- No
Original drug
Noxafil, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680651720019
CHF 456.15